Appropriate Evaluation of Antiviral Therapy With Nirmatrelvir-ritonavir in Hospitalized Patients
Condition: Hospitalized Patients Intervention: Drug: Nirmatrelvir-Ritonavir Sponsors: First People's Hospital of Hangzhou; Hangzhou Cancer Hospital; First People's Hospital of Lin'an District; First People's Hospital of Yuhang District Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 1, 2023 Category: Research Source Type: clinical trials
Improving Response to Immunotherapy in Patients With Advanced Hepatocellular Carcinoma and Chronic Hepatitis C Virus Infection With Direct-Acting Antiviral Therapy
Condition: Liver Cancer Interventions: Drug: Bevacizumab; Drug: Atezolizumab; Drug: Sofosbuvir; Drug: Velpatasvir; Drug: Voxilaprevir; Drug: Ribavirin Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 8, 2023 Category: Research Source Type: clinical trials